Dataset: CDK inhibitor PHA-848125 gene expression profiling on MCF7 cell line

The effects of the CDK inhibitor PHA-848125 (referred to as CDK-125) on the MCF7 human adenocarcinoma mammary cell line were analysed by gene expression profiling. The MCF7 cell line was treated with PHA-848125 for 6 hours at a dose equal to 5 times the IC50. Untreated MCF7 cells were used as a control. Two replicates per treatment.

Species:

human

Samples:

4

Source:

E-GEOD-18501

PubMed:

20679242

Updated:

Dec.12, 2014

Registered:

Sep.15, 2014